Apple's Supply Squeeze May Last Into 2027-Why UBS Thinks the Stock Still Has Limited Upside

UBS sees Apple's post-earnings reset as a longer valuation issue

Apple shares fell nearly 10% following its latest earnings report as investors absorbed supply constraints, rising memory costs, and a tougher margin outlook. The bigger concern is not one uneven quarter. It is that supply chain-related concerns could persist into fiscal 2027.

That matters because the stock had recently rerated on optimism. When a company has already gained sharply, weaker news on capacity and costs can quickly turn the story into a "show me" setup.

Why Apple's supply and cost pressures could linger

UBS argues that Apple's latest quarter looked acceptable on the surface, but underlying operations look harder. The firm said supply constraints are expected to "increase significantly sequentially" across iPhone, Mac and iPad production. When build rates fall short, sales can be capped even if demand stays healthy.

Profitability is the other pressure point. Higher memory costs and rising component expenses can compress margins, and gross margin excluding tariff refunds was 48.1%, leaving less room for additional cost inflation.

Why UBS sees limited upside to Apple shares

This is why UBS maintained a 'Neutral' rating and pointed to limited upside to estimates. The firm cited an elevated valuation after the recent run-up in the stock, and it warned that higher memory costs, increasing component expenses, and fading tariff-related benefits could keep pressure on margins.

The near-term debate is less about Apple's long-term brand and more about whether this supply squeeze remains a temporary bottleneck or becomes a multi-quarter drag on volume and profitability.